Mary Grecco

DocwireNews

Interception-Lung is a French, soon to be nationally deployed, community hospital and digital-physical, personalized, pilot lung cancer screening and prevention program with an ultimate objective of reducing the incidence of advanced lung cancer. Results of a study that occurred between 2021 and 2023 and examined the impact of the program were presented at the ESMO Congress 2023.
Men and women aged 50 years and older who were active or former smokers (quit ≤10 years) were eligible to be invited to attend a “One Stop Shop” that included personalized prevention consultations, counseling on smoking cessation, and lung cancer screening with low-dose computed tomography (LDCT) on the basis of a shared medical decision, as well as educational group workshops on smoking and lung cancer, nutrition, and physical activity. Screening outcome was either positive, negative, or indeterminate, as per the European position statement on lung cancer screening recommendations. A total of 276 individuals (187 of whom were women, with a median age of 57 years) attended the One Stop Shop between May 2021 and 2023. Among the group, 54% had post-high school training or were college educated; 73% were active smokers; 15% were regular cannabis users; and 16% reported any use of vape. The researchers found that 37% had a previous history of another cancer (mainly breast). Median 6-year lung cancer risk according to the PLCOm2012noRace prediction model was 1.4% (range, 0.7%-2.9%).
Results of the first screening round were negative, indeterminate, and positive in 65%, 31%, and 4% of the participants, respectively. Five participants had surgery, three had lung cancer (stage I adenocarcinoma), and two had a benign histology. The researchers found the proportion of indeterminate screenings decreased from 31% to 8% at the second round. Among 56 initially active smokers with already available extended follow-up data, 12 (21%) were abstinent at 1 year from the One Stop Shop.
The researchers concluded that “a combined intervention mixing lung cancer screening and prevention is feasible and could increase the benefit of LDCT screening and long-term smoking cessation rates. Reducing false-positives and improving risk-based identification and referral for screening is a major challenge.”
Source: Abdayem P. Early impact of a personalized lung cancer interception program for heavy smokers. Abstract of a poster presented at the ESMO Congress 2023; October 20-24, 2023; Madrid, Spain.

Laura Litwin

CHRYSALIS External Control Analysis Sheds Light on Real-World Treatments, Outcomes in NSCLC

EGFR+ NSCLC

Increase in Cardiopulmonary Disease Burden Associated With Cross-Country Wildfire Smoke

Cardiology

Rob Dillard

Landmark Proposal: FDA Wants Big Tobacco to Lower Nicotine Levels in Cigarettes

Latest News

Reducing the Incidence of Advanced Lung Cancer With Interception-Lung: A Study of a Personalized Pilot Lung Cancer Screening and Prevention Program

ESMO 2023: Focus on Lung Cancer

A study examined the impact of the Interception-Lung program, which aims to reduce the incidence of advanced lung cancer.

Reducing the Incidence of Advanced Lung Cancer With Interception-Lung

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe